Journal rankings · indicator year 2015
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Subfield ranking · 2015
Infectious Diseases journal rankings 2015
182 ranked journals · Subfield in Medicine
Infectious Diseases has 182 ranked journals in 2015. The median journal has an OJR of 0.87, below the world average of 1.00, down 0.03 on 2014; Q1 starts at OJR 1.38. The top three are New England Journal of Medicine, Clinical Microbiology Reviews, and PLoS Medicine.
Ranks and citation indicators: 2015. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2012–2014, the window the 2015 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields of Medicine (42)
- Surgery773
- Pulmonary and Respiratory Medicine297
- Public Health, Environmental and Occupational Health252
- Cardiology and Cardiovascular Medicine238
- Oncology188
- Infectious Diseases182
- Epidemiology176
- Neurology151
- Endocrinology, Diabetes and Metabolism141
- Radiology, Nuclear Medicine and Imaging138
- Physiology129
- Psychiatry and Mental health123
Show all 42 subfields
- Orthopedics and Sports Medicine95
- Pediatrics, Perinatology and Child Health85
- Dermatology74
- Ophthalmology74
- Hematology71
- Obstetrics and Gynecology61
- Rheumatology58
- Nephrology49
- Reproductive Medicine45
- Complementary and alternative medicine42
- Pharmacology42
- Emergency Medicine36
- Geriatrics and Gerontology36
- Otorhinolaryngology34
- Rehabilitation29
- Pathology and Forensic Medicine23
- Critical Care and Intensive Care Medicine22
- Genetics19
- Hepatology19
- Immunology and Allergy17
- Anesthesiology and Pain Medicine12
- Urology11
- Gastroenterology6
- Internal Medicine5
- Family Practice3
- Transplantation3
- Health Informatics1
- Anatomy0
- Biochemistry0
- Microbiology0
182 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2014. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2012–2014, the window the 2015 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2012–2014 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2006 to 2015. | Compare |
|---|---|---|---|---|---|---|---|
1New England Journal of MedicineMassachusetts Medical Society · United States | 15.60Q1 | 31.40 2.48 up from 2014 | 2,796 | 38% | — | ||
2Clinical Microbiology ReviewsAmerican Society for Microbiology · United States | 11.45Q1 | 21.92 3.00 down from 2014 | 104 | 100% | — | ||
3PLoS MedicineOAPublic Library of Science · United States | 5.34Q1 | 12.03 0.34 up from 2014 | 613 | 100% | $6,460 | ||
4Annals of Internal MedicineAmerican College of Physicians · United States | 4.33Q1 | 8.31 0.51 down from 2014 | 1,296 | 11% | — | ||
5The Lancet Infectious DiseasesElsevier BV · Netherlands | 3.87Q1 | 9.83 0.12 down from 2014 | 719 | 44% | $7,280 | ||
6PLoS PathogensOAPublic Library of Science · United States | 3.63Q1 | 8.31 1.07 down from 2014 | 2,065 | 100% | $3,043 | ||
7The Lancet Global HealthOAElsevier BV · Netherlands | 3.55Q1 | 5.54 1.22 up from 2014 | 294 | 100% | $6,680 | ||
8Clinical Infectious DiseasesOxford University Press · United States | 3.33Q1 | 7.36 0.75 down from 2014 | 2,070 | 51% | $4,763 | ||
9EurosurveillanceOAEuropean Centre for Disease Prevention and Control · Sweden | 2.91Q1 | 6.96 0.34 up from 2014 | 673 | 100% | — | ||
10The Journal of Infectious DiseasesOxford University Press · United States | 2.59Q1 | 5.96 0.11 down from 2014 | 1,956 | 69% | $4,763 | ||
11Emerging infectious diseasesOACenters for Disease Control and Prevention · United States | 2.58Q1 | 5.56 0.19 up from 2014 | 1,695 | 100% | — | ||
12The Indian Journal of Medical ResearchOAMedknow · India | 2.48Q1 | 4.00 1.72 down from 2014 | 46 | 100% | — | ||
13Clinical Microbiology and InfectionElsevier BV · United Kingdom | 2.27Q1 | 4.82 0.82 down from 2014 | 998 | 99% | $3,780 | ||
14VirulenceOATaylor & Francis · United States | 2.25Q1 | 5.69 0.62 up from 2014 | 290 | 100% | $2,557 | ||
15Antiviral ResearchElsevier BV · Netherlands | 2.09Q1 | 5.30 0.44 up from 2014 | 611 | 39% | $4,160 | ||
16Current Opinion in HIV and AIDSLippincott Williams & Wilkins · United Kingdom | 2.08Q1 | 5.14 0.55 down from 2014 | 238 | 55% | — | ||
17International Journal of Medical MicrobiologyOAElsevier BV · Germany | 2.02Q1 | 4.49 0.32 up from 2014 | 301 | 20% | $3,410 | ||
18Emerging Microbes & InfectionsOATaylor & Francis · United Kingdom | 1.99Q1 | 4.88 1.70 up from 2014 | 119 | 100% | $2,643 | ||
19Current HIV/AIDS ReportsSpringer Science+Business Media · United States | 1.98Q1 | 4.99 0.09 down from 2014 | 130 | 63% | $4,190 | ||
20VirusesOAMultidisciplinary Digital Publishing Institute · Switzerland | 1.96Q1 | 4.12 0.60 down from 2014 | 631 | 100% | $3,137 | ||
21Infection and Drug ResistanceOADove Medical Press · New Zealand | 1.94Q1 | 4.70 1.78 up from 2014 | 83 | 100% | $2,836 | ||
22AIDSLippincott Williams & Wilkins · United Kingdom | 1.92Q1 | 4.51 0.52 down from 2014 | 1,195 | 55% | — | ||
23Journal of Clinical MicrobiologyOAAmerican Society for Microbiology · United States | 1.90Q1 | 4.11 0.43 down from 2014 | 2,405 | 100% | — | ||
24Journal of Antimicrobial ChemotherapyOxford University Press · United Kingdom | 1.88Q1 | 4.60 0.63 down from 2014 | 1,608 | 58% | $3,784 | ||
25The Lancet HIVElsevier BV · Netherlands | 1.82Q1 | 4.00no 2014 value | 34 | 45% | $7,280 | — | |
26Antimicrobial Agents and ChemotherapyOAAmerican Society for Microbiology · United States | 1.82Q1 | 4.65 0.32 down from 2014 | 3,033 | 100% | — | ||
27Future MicrobiologyFuture Medicine · United Kingdom | 1.80Q1 | 3.74 0.64 down from 2014 | 369 | 26% | — | ||
28FEMS Immunology & Medical MicrobiologyOxford University Press · Netherlands | 1.75Q1 | —no 2014 value | 102 | — | — | ||
29JAIDS Journal of Acquired Immune Deficiency SyndromesLippincott Williams & Wilkins · United States | 1.69Q1 | 4.01 0.18 down from 2014 | 1,169 | 64% | — | ||
30Journal of General VirologyMicrobiology Society · United Kingdom | 1.67Q1 | 3.64 0.05 down from 2014 | 903 | 40% | — | ||
31AIDS and BehaviorSpringer Science+Business Media · Netherlands | 1.65Q1 | 3.67 0.31 down from 2014 | 845 | 76% | $4,590 | ||
32Reviews in Medical VirologyWiley · United Kingdom | 1.64Q1 | 4.71 0.45 down from 2014 | 90 | 34% | $4,880 | ||
33AnaerobeElsevier BV · United Kingdom | 1.61Q1 | 3.14 0.06 down from 2014 | 345 | 18% | $3,350 | ||
34BMC Infectious DiseasesOABioMed Central · United Kingdom | 1.60Q1 | 3.73 0.08 down from 2014 | 1,775 | 100% | $3,090 | ||
35British Journal of Clinical PharmacologyWiley · United Kingdom | 1.59Q1 | 3.43 0.17 down from 2014 | 798 | 96% | $4,780 | ||
36World Journal of VirologyOAUnited States | 1.58Q1 | 2.91 0.13 up from 2014 | 42 | 100% | — | ||
37AIDS Education and PreventionGuilford Press · United States | 1.54Q1 | 2.37 0.23 down from 2014 | 126 | 51% | — | ||
38Journal of InfectionOAElsevier BV · United Kingdom | 1.54Q1 | 3.68 0.06 up from 2014 | 585 | 20% | $4,030 | ||
39Clinical and Experimental Vaccine ResearchOASeoul : Korean Vaccine Society · South Korea | 1.46Q1 | 3.31 0.91 up from 2014 | 59 | 100% | — | ||
40Infection Control and Hospital EpidemiologyCambridge University Press · United Kingdom | 1.45Q1 | 2.69 0.84 down from 2014 | 960 | 54% | $3,550 | ||
41Tropical Medicine & International HealthWiley · United Kingdom | 1.44Q1 | 2.94 0.25 up from 2014 | 567 | 59% | $3,400 | ||
42HIV MedicineWiley · United Kingdom | 1.44Q1 | 3.35 0.05 down from 2014 | 304 | 63% | $4,150 | ||
43Expert Review of Anti-infective TherapyTaylor & Francis · United Kingdom | 1.42Q1 | 3.71 0.28 up from 2014 | 423 | 27% | — | ||
44Infection Genetics and EvolutionOAElsevier BV · Netherlands | 1.39Q1 | 3.09 0.20 down from 2014 | 982 | 27% | $2,730 | ||
45AIDS Patient Care and STDsMary Ann Liebert, Inc. · United States | 1.38Q1 | 3.99 0.10 up from 2014 | 287 | 73% | — | ||
46PathogensOAMultidisciplinary Digital Publishing Institute · Switzerland | 1.38Q1 | 3.30 1.27 up from 2014 | 98 | 100% | $2,654 | ||
47Antimicrobial Resistance and Infection ControlOABioMed Central · United Kingdom | 1.37Q2 | 3.57 0.23 up from 2014 | 131 | 100% | $3,290 | ||
48Virology JournalOABioMed Central · United Kingdom | 1.34Q2 | 3.01 0.02 down from 2014 | 915 | 100% | $3,290 | ||
49Interdisciplinary Perspectives on Infectious DiseasesOAHindawi Publishing Corporation · United Kingdom | 1.34Q2 | 2.43 0.18 down from 2014 | 86 | 100% | $860 | ||
50Virus ResearchOAElsevier BV · Netherlands | 1.33Q2 | 2.65 0.09 down from 2014 | 849 | 33% | $3,010 |
Subfields of Medicine, with Infectious Diseases highlighted.
- Surgery773
- Pulmonary and Respiratory Medicine297
- Public Health, Environmental and Occupational Health252
- Cardiology and Cardiovascular Medicine238
- Oncology188
- Infectious Diseases182
- Epidemiology176
- Neurology151
- Endocrinology, Diabetes and Metabolism141
- Radiology, Nuclear Medicine and Imaging138
- Physiology129
- Psychiatry and Mental health123
- Orthopedics and Sports Medicine95
- Pediatrics, Perinatology and Child Health85
- Dermatology74
- Ophthalmology74
- Hematology71
- Obstetrics and Gynecology61
- Rheumatology58
- Nephrology49
- Reproductive Medicine45
- Complementary and alternative medicine42
- Pharmacology42
- Emergency Medicine36
- Geriatrics and Gerontology36
- Otorhinolaryngology34
- Rehabilitation29
- Pathology and Forensic Medicine23
- Critical Care and Intensive Care Medicine22
- Genetics19
- Hepatology19
- Immunology and Allergy17
- Anesthesiology and Pain Medicine12
- Urology11
- Gastroenterology6
- Internal Medicine5
- Family Practice3
- Transplantation3
- Health Informatics1
- Anatomy0
- Biochemistry0
- Microbiology0
Journals
Citations made in 2015. Corpus-wide, 78.1% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
45 additional Infectious Diseases journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2012–2014, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2015. Publication window: 2012–2014. How these summaries are calculated
- Ranked journals
- 182
- Window papers (baseline)
- 62,728 +20.4% from indicator year 2012
- Median OJR
- 0.874 -9.5% from indicator year 2012
- Rising journals (2025)
- 48
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2012–2014 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 70 | 73 | 78 | 82 | 86 | 92 | 95 | 101 | 106 | 110 | 118 | 131 | 144 | 162 | 173 | 182 | 189 | 198 | 210 | 217 | 222 | 234 | 243 | 259 | 263 | 258 | |
| Window papers (baseline) | 18,375 | 21,167 | 22,805 | 24,640 | 25,208 | 28,008 | 31,333 | 35,063 | 38,170 | 42,272 | 46,364 | 49,515 | 52,080 | 54,445 | 58,513 | 62,728 | 67,259 | 69,548 | 70,742 | 70,658 | 72,743 | 100,768 | 135,954 | 162,915 | 153,103 | 130,899 | |
| Median OJR | 0.602 | 0.68 | 0.82 | 0.76 | 0.77 | 0.901 | 0.98 | 0.93 | 1.04 | 0.998 | 1.01 | 0.999 | 0.97 | 0.900 | 0.91 | 0.874 | 0.85 | 0.8699 | 0.8696 | 0.83 | 0.80 | 0.597 | 0.61 | 0.64 | 0.70 | 0.75 |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.